UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2319-2333

2001

Volltextzugriff (PDF)

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2986-2999

1998

Volltextzugriff (PDF)

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

Annals of oncology, 2001-08, Vol.12 (8), p.1067-1073

2001

Volltextzugriff (PDF)

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103

Journal of clinical oncology, 1993-12, Vol.11 (12), p.2405-2410

1993

Volltextzugriff (PDF)

Clinical pharmacology of UCN-01 : initial observations and comparison to preclinical models

Cancer chemotherapy and pharmacology, 1998-08, Vol.42 (S1), p.S54-S59

1998

Volltextzugriff (PDF)

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2056-2065

1995

Volltextzugriff (PDF)

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

Journal of clinical oncology, 1991-12, Vol.9 (12), p.2128-2133

1991

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1492-1501

1997

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Journal of clinical oncology, 2000-02, Vol.18 (3), p.659-667

2000

Volltextzugriff (PDF)

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1236-1244

1996

Volltextzugriff (PDF)

Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2905-2909

1997

Volltextzugriff (PDF)

Relation of systemic exposure to unbound etoposide and hematologic toxicity

Clinical pharmacology and therapeutics, 1991-10, Vol.50 (4), p.385-393

1991

Volltextzugriff (PDF)

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

Journal of clinical oncology, 1993-09, Vol.11 (9), p.1737-1745

1993

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma

Journal of clinical oncology, 1994-03, Vol.12 (3), p.560-568

1994

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of a 3-Hour Infusion of Paclitaxel followed by Cisplatinum and 5-Fluorouracil in Patients with Advanced Solid Tumors

Clinical cancer research, 1999-07, Vol.5 (7), p.1723-1730

1999

Volltextzugriff (PDF)

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

Clinical cancer research, 1999-09, Vol.5 (9), p.2381-2391

1999

Volltextzugriff (PDF)

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia

Annals of oncology, 1999-05, Vol.10 (5), p.577-583

1999

Volltextzugriff (PDF)

Altered protein binding of etoposide in patients with cancer

Clinical pharmacology and therapeutics, 1989-01, Vol.45 (1), p.49-55

1989

Volltextzugriff (PDF)

Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients

Cancer research (Chicago, Ill.), 1990-11, Vol.50 (21), p.6854-6856

1990

Volltextzugriff (PDF)

Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF

European journal of cancer (1990), 1996-04, Vol.32 (4), p.631-635

1996

Volltextzugriff (PDF)

Seizures Associated With Leucovorin Administration in Cancer Patients

JNCI : Journal of the National Cancer Institute, 1995-01, Vol.87 (1), p.56-58

1995

Volltextzugriff (PDF)

Etoposide pharmacokinetics in patients with normal and abnormal organ function

Journal of clinical oncology, 1986-11, Vol.4 (11), p.1690-1695

1986

Volltextzugriff (PDF)

A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (20), p.4828-4836

1993

Volltextzugriff (PDF)

Primary therapy of multiple myeloma with paclitaxel (Taxol)

Annals of oncology, 1994-10, Vol.5 (8), p.757-759

1994

Volltextzugriff (PDF)

A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients

Cancer chemotherapy and pharmacology, 2001-09, Vol.48 (3), p.215-222

2001

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Middle Aged
(48)
Female
(47)
Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Aged
(45)
Oncology
(42)
Biological And Medical Sciences
(40)
Medical Sciences
(39)
Pharmacology. Drug Treatments
(38)
Antineoplastic Agents
(35)
Male
(34)
Chemotherapy
(26)
Neoplasms - Drug Therapy
(19)
Infusions, Intravenous
(17)
Drug Administration Schedule
(16)
Antineoplastic Agents - Administration & Dosage
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Treatment Outcome
(12)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103

Clinical pharmacology of UCN-01 : initial observations and comparison to preclinical models

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients

Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma

Relation of systemic exposure to unbound etoposide and hematologic toxicity

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma

Phase I and Pharmacologic Study of a 3-Hour Infusion of Paclitaxel followed by Cisplatinum and 5-Fluorouracil in Patients with Advanced Solid Tumors

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia

Altered protein binding of etoposide in patients with cancer

Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients

Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF

Seizures Associated With Leucovorin Administration in Cancer Patients

Etoposide pharmacokinetics in patients with normal and abnormal organ function

A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma

Primary therapy of multiple myeloma with paclitaxel (Taxol)

A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients

Aktive Filter

Suchergebnisse filtern